期刊文献+

ROC曲线评价空腹C肽水平应用于2型糖尿病肾病临床诊断价值 被引量:4

Clinical vaule of ROC curve evaluating fasting C-peptide for diagnostic of type 2 diabetic nephropathy
下载PDF
导出
摘要 目的探讨2型糖尿病(DM)患者空腹血清C肽(FCP)水平应用于糖尿病肾病(DN)的诊断意义,并采用ROC曲线选择最佳临界值并评价诊断性能。方法回顾性分析本院2006年6月至2009年8月间342例2型DM患者,其中DM组254例,DN组88例。ROC曲线选择FCP的临界值,并以此评价FCP检测值的诊断价值。结果 1)DN组FCP水平显著低于DM组(P=0.000,t=7.385),FCP诊断DN的临界值为1.20ng/mL,ROC曲线下面积为0.884±0.021,95%置信区间(95%CI)为0.844~0.925;2)诊断灵敏度为90.8%,特异性为78.0%,阳性预期值为92.9%,阴性预期值为72.7%,正确率为87.7%,Youden值为68.8%;3)DN的分期随FCP浓度的降低而逐渐升高(χ2=154.49,P<0.001),队列研究结果显示:RR=3.407,95%CI为2.418~4.800。结论 FCP水平与2型DM患者中DN的发生、发展密切相关,DM患者FCP水平低于1.20ng/mL时发生DN的风险增加,保持生理性的C肽浓度可能会延缓DN的发生与发展。 Objective To explore the diagnostic significance Of fasting connecting peptide(FCP) for diagnostic of type 2 Diabetic nephropathy(DN). The cut-off vaule of FCP was chosen by Receiver Operation Charaeteristie(ROC), and these efficiency index were evaluated,respectively. Methods 342 patients with DM in our hospital during June of 2006 to August of 2009 by retrospective analysis. 254 patients were in the group of DM and 88 in DN group,respectively. Results 1)The FCP level in DN group was sijnifieant lower than it in DM group,P=0. 000,t=7. 385 and the cut-off vaule was 1.20 ng/mL. Area under the curve was 0. 884 ± 0. 021, Asymptotic 95 % Confidence Interval(95 % CI) was 0. 844- 0. 925.2) Their Sensitivity, Specificity, Positive predict vaule, Negative pretict vaule, exactitude and Youden avule were 90.8 %, 78.0 %, 92.9 %, 72.7 %, 87.7 % and 68.8 %, respectively. 3) Along with the FCP level descend,The stages of DN was hoist gradually(x^2= 154.49, P〈0. 001). Risk Estimate was 3. 407, 95%CI was 2. 418-4. 800. Conclusion There is intimate eorrelation between FCP level with the stages of DN. The risk factor of oecuring DN in FCP〈1. 20 ng/mL was higher than FCP〉1. 20 ng/mL. Remaining physiological FCP concentration in the patients with DM may delay its development of DN.
出处 《国际检验医学杂志》 CAS 2010年第11期1265-1266,1269,共3页 International Journal of Laboratory Medicine
关键词 C肽 糖尿病肾病 ROC曲线 诊断 C peptide diabetic nephropathies ROC curve diagnosis
  • 相关文献

参考文献13

  • 1张培培,刘志红.糖尿病肾病患者肾功能的评估[J].肾脏病与透析肾移植杂志,2007,16(6):558-563. 被引量:13
  • 2Worthley DL,Harvey NT,Hill NL,et al.Urinary transferrin and albumin concentrations in patients with type 1 diabetes and normal controls:the search for the first protein lost[J].Clin Biochem,2001,34(1):83-85.
  • 3Wahren J,Ekberg K,Samnegard B,et al.C-peptide:a new potential in the treatment of diabetic nephropathy[J].Curr Diab Rep,2001,1(3):261-266.
  • 4Huang DY,Richter K,Breidenbach A,et al.Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats:a dose-response study[J].Naunyn Schmiedebergs Arch Pharmacol,2002,365(1):67-73.
  • 5Wahern J.C-PePtide:new findings and therapeutie implieations in diabetes[J].Clin Physiol Funct Imaging,2004,24:180-189.
  • 6Chen GJ,Adeyemo A,Zhou J,et al.Genome-wide search for susceptibility genes to type 2 diabetes in West Africans:Potential role of C-peptide[J].Diabetes Res Clin Pract,2007,78(3):e1-6.
  • 7Fernandez E,Bernall E,Sanchez O,et al.C-peptide as a new hypertensive factor in patients with type 2 diabetes mellitus[J].Am J Hypertens,2005,18:179A.
  • 8Fernandez E,Sanchez O,Sanchez-Largo E,et al.The influence of C-peptide on the early-stage blood pressure control in type 2 diabetic patients[J].Atherosclerosis supplements,2005,6(1):133.
  • 9Rebsomen L,Pitel S,Boubred F,et al.C-peptide replacement improves weight gain and renal function in diabetic rats[J].Diabetes Metab,2006,32(3):223-228.
  • 10Singh RP,Rogers J,Farney AC,et al.Do Pretransplant C-Peptide Levels Influence Outcomes in Simultaneous Kidney-Pancreas Transplantation[J].Transplant Proc,2008,40:510-512.

二级参考文献43

  • 1Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function . Annu Rev Med,1988,39:465 -490.
  • 2Levey AS, Berg RL, Gassman J J, et al. Creatinine filtration, secretion and excretion during progressive renal disease. Kidney lnt, 1989,36 ( Suppl 27 ) : S73 - S80.
  • 3Norden G,Biorck S, Granerus G, et al. Estimation of renal function in diabetic nephropathy-comparison of five methods. Nephron,1987, 47(1) :36 -42.
  • 4Joint Speciality Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, the Royal College of General Practitioners: Chronic Kidney Disease in Adults: UK Guidelines forI- dentification, Management and Referral. London, Royal College of Physicians,2006,15 - 19.
  • 5European Best Practice Guidelines for Haemodialysis ( Part 1 ) : Section I: measurement of renal functions, when to refer and when to start dialysis. Nephrol Dial Transplant,2002, 17 ( Suppl. 7) : S7 -15.
  • 6National Kidney Foundation: K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kid Dis, 2002, 39 (Suppl. 2) :S1 - S266.
  • 7Poggio ED, Wang X, Greene T, et al. Performance of the modification of diet in renal disease and Cockroft Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol, 2005,16:459 - 466.
  • 8Vervoort G, WiUems HL, Wetzels JF. Assessment of glomerular illtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant, 2002, 17:1909 - 1913.
  • 9Bossing P, Bossing K, Gaede P, et al. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care, 2006, 29 : 1024 - 1030.
  • 10Lin J, Knight EL, Hogan ML, et al. A Comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol, 2003, 14:2573 -2580.

共引文献15

同被引文献36

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部